Clinical Trials on Influenza Infection in Netherlands

Total 1305 results

Radboud University Medical Center

Completed

Effects of BCG on Influenza Induced Immune Response

Trained Immunity | Influenza Virus Infection

Netherlands
Radboud University Medical Center
GlaxoSmithKline

Completed

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Influenza | Herpes Zoster

Netherlands
PepTcell Limited
Norwegian Institute of Public Health; University Medical Center Groningen; University... and other collaborators

Completed

A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

Influenza

Netherlands
University Medical Center Groningen
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers

Influenza

Netherlands
The Archer-Daniels-Midland Company
NIZO Food Research

Completed

Probiotics and Influenza Vaccination Response (VERB)

Vaccine Response

Netherlands
National Institute for Public Health and the Environment...
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes (PEPpIE)

Influenza

Netherlands
Maastricht University Medical Center
Scelta Mycofriends B.V.; CNC Grondstoffen B.V.

Recruiting

Agaricus Bisporus and Influenza Vaccination Response

Immune Response

Netherlands
Maastricht University Medical Center
Raisio Nutrition Ltd.

Completed

Plant Stanol Esters and Influenza Vaccination

Immune Response

Netherlands
Leiden University Medical Center
Erasmus Medical Center

Completed

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza (RICH-3)

HIV

Netherlands
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

Pandemic Influenza

Netherlands, Belgium, Chile, Dominican Republic, Germany
UMC Utrecht
Boehringer Ingelheim

Completed

Screening for Silent Atrial Fibrillation During Influenza Vaccination

Atrial Fibrillation

Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Influenza

Sweden, Netherlands
Radboud University Medical Center

Recruiting

Prospective Observational Trial of IAPA (IAPAFLU)

Pulmonary Aspergillosis | Influenza With Pneumonia

Belgium, France, Netherlands
Poolbeg Pharma plc

Completed

Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses

Influenza, Human

Netherlands
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Healthy Volunteers | Influenza Immunization

France, Belgium, Germany, Italy, Netherlands, Poland
Universitaire Ziekenhuizen KU Leuven
Merck Sharp & Dohme LLC

Completed

Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients (POSA-FLU)

Aspergillosis; Pulmonary, Invasive (Etiology)

Belgium, Netherlands
Hoffmann-La Roche

Completed

Influenza Resistance Information Study (IRIS)

Influenza

Australia, Hong Kong, United States, France, Germany, Netherlands, Norway, Poland
Novartis Vaccines

Completed

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

Influenza

Italy, Argentina, Netherlands
GlaxoSmithKline

Recruiting

An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection

Arthralgia | Influenza, Human

Spain, United Kingdom, Poland, Netherlands
GlaxoSmithKline

Completed

Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older

Influenza

Germany, Sweden, Netherlands
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People

Influenza

Germany, Sweden, Netherlands
St. Antonius Hospital

Completed

Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy (RIFLUVAC)

Heart Failure | Mamma Carcinoma

Netherlands
Ology Bioservices

Completed

Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups

Influenza

Austria, Belgium, Finland, Germany, Latvia, Lithuania, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A

Influenza

Germany, Sweden, United Kingdom, Netherlands
Radboud University Medical Center

Completed

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID-I)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection

Influenza A Virus

United States, France, Belgium, Germany, Hong Kong, Spain, Malaysia, Turkey, Canada, Netherlands, Singapore, Brazil, New Zealand, Australia, Sweden
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Palatability Testing of a New Paediatric Formulation of Valacyclovir (VALID-0)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Influenza

France, Spain, Germany, Russian Federation, Estonia, Sweden, Netherlands
Novartis Vaccines

Completed

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

A New Flu Virus of Swine Origin | Pandemic Influenza A (H1N1)

Argentina, Netherlands
Radboud University Medical Center

Terminated

Pharmacokinetics of Valacyclovir Oral Solution in Children (VALID2)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
Adamas Pharmaceuticals, Inc.

Completed

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects (PO206)

Influenza

United States, Australia, Canada, Netherlands, Singapore
GlaxoSmithKline

Completed

Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™

Influenza

United States, Germany, Poland, Netherlands
International Antiviral Therapy Evaluation Center
Gilead Sciences

Completed

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

HIV Infections | Hepatitis B

Netherlands
ModernaTX, Inc.

Completed

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

Seasonal Influenza

Spain, United States, Denmark, Poland, United Kingdom, Germany, Canada, Taiwan, Bulgaria, Netherlands, Estonia
Janssen Research & Development, LLC

Terminated

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Influenza A

United States, France, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Israel, India, Thailand, New Zealand, Vietnam, Germany, Latvia, Spain, Russian Federation, Turkey, Argentina, Singapore, Brazil, Hungary, Malaysia, Au... and more
Leiden University Medical Center

Completed

Immunisation, Treatment and Controlled Human Hookworm Infection (ITCHHI)

Necator Americanus Infection

Netherlands
Leiden University Medical Center

Completed

Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical Center (CHHIL)

Necator Americanus Infection

Netherlands
Meta Roestenberg

Completed

Repeated Controlled Human Hookworm Infection (ReCHHI1)

Necator Americanus Infection

Netherlands
Seqirus

Active, not recruiting

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Quadrivalent Influenza Vaccine Compared to a Non-adjuvanted Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age

Influenza, Human

Turkey, Belgium, Bulgaria, Czechia, Finland, Georgia, Italy, Korea, Republic of, Lithuania, Netherlands, Poland, Romania, Spain, Taiwan
Janssen Research & Development, LLC

Terminated

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications

Influenza A

United States, France, Korea, Republic of, Taiwan, China, India, Argentina, Israel, Thailand, Vietnam, Hungary, Germany, South Africa, Spain, Turkey, Belgium, Brazil, Canada, Mexico, New Zealand, Bulgaria, Peru, Malaysia, Italy, Estonia, ... and more
University Medical Center Groningen
Pfizer

Completed

Effect of Inflammation on Voriconazole Concentration

Inflammation | Fungal Infection

Netherlands
St. Antonius Hospital

Completed

Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab (Rituxivac)

Non-Hodgkin Lymphoma (NHL)

Netherlands
University Medical Center Nijmegen
Dutch Kidney Foundation

Completed

Genital HPV Infections Before and After Renal Transplantation

Human Papillomavirus Infections

Netherlands
AM-Pharma

Withdrawn

Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients

Fungal Infection | Bacterial Infection

Netherlands
Radboud University Medical Center
GlaxoSmithKline

Completed

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir (EPOS)

HIV Infection | Fungal Infection

Netherlands
Crucell Holland BV
National Institutes of Health (NIH); Division of Microbiology and Infectious...

Withdrawn

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Influenza

United States, Australia, Canada, France, Germany, Spain, Belgium, Bulgaria, Netherlands, Brazil, South Africa, Sweden
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin in Patients Intensive Care Unit (MIMIC)

Invasive Fungal Infection

Netherlands
Radboud University Medical Center
UMC Utrecht; Rijnstate Hospital; Canisius-Wilhelmina Hospital; Gelderse Vallei... and other collaborators

Completed

Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients (FANATIC)

Bacterial Infections

Netherlands
Princess Amalia Children's Clinic

Completed

Co-infections in Children Hospitalised for Bronchiolitis

Bronchiolitis

Netherlands
Radboud University Medical Center
Sint Maartenskliniek

Active, not recruiting

Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen. (REViSION)

Surgical Site Infection | Joint Infection | Infection, Surgical Site | Infection Prosthesis Hip and Knee | Infection, Prosthesis Related | Infection Pro

Netherlands

Clinical Trials on Influenza Infection in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations